Multiple components of the B cell antigen receptor complex associate with the protein tyrosine phosphatase, CD45. 1994

V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543.

Signal transduction via the B cell antigen receptor complex is regulated by changes in tyrosine phosphorylation of several proteins. The equilibrium between tyrosine phosphorylation and dephosphorylation is regulated by the combined action of protein tyrosine kinase and protein tyrosine phosphatase enzymes. In particular, the protein tyrosine phosphatase, CD45, has been shown to play an essential role in signal transduction via the B cell antigen receptor. Therefore, experiments were performed to examine the intermolecular associations between CD45 and phosphotyrosine-containing proteins in the B cell to identify potential substrates for CD45. Based on coprecipitation experiments, CD45 was found to be physically associated with multiple components of the B cell antigen receptor complex including the MB-1/B29 heterodimer. Additionally, CD45 was selectively associated with the src family protein tyrosine kinase, lyn. Neither blk nor fyn were observed to interact with CD45 even though they have been implicated in antigen receptor signal transduction. This finding suggests that CD45 may preferentially regulate the phosphorylation of lyn and thus, its activity. In summary, these studies provide evidence to support the hypothesis that CD45 regulates antigen receptor-mediated signal transduction by controlling the tyrosine phosphorylation of multiple components of the antigen receptor complex.

UI MeSH Term Description Entries
D007072 Immunoglobulin D An immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES. IgD,IgD1,IgD2
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D007147 Immunoglobulin Light Chains Polypeptide chains, consisting of 211 to 217 amino acid residues and having a molecular weight of approximately 22 kDa. There are two major types of light chains, kappa and lambda. Two Ig light chains and two Ig heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) make one immunoglobulin molecule. Ig Light Chains,Immunoglobulins, Light-Chain,Immunoglobulin Light Chain,Immunoglobulin Light-Chain,Light-Chain Immunoglobulins,Chains, Ig Light,Chains, Immunoglobulin Light,Immunoglobulins, Light Chain,Light Chain Immunoglobulins,Light Chain, Immunoglobulin,Light Chains, Ig,Light Chains, Immunoglobulin,Light-Chain, Immunoglobulin
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009665 Noscapine A naturally occurring opium alkaloid that is a centrally acting antitussive agent. Narcotine,Capval,Capval Tropfen,Librochin Prikkelhoest,Noscapect,Noscapine Hydrochloride,Noscapine Hydrogen Embonate,Tuscalman,Embonate, Noscapine Hydrogen,Hydrochloride, Noscapine,Hydrogen Embonate, Noscapine,Prikkelhoest, Librochin,Tropfen, Capval
D010750 Phosphoproteins Phosphoprotein

Related Publications

V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
November 1992, Journal of immunology (Baltimore, Md. : 1950),
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
October 1988, Proceedings of the National Academy of Sciences of the United States of America,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
September 1990, Proceedings of the National Academy of Sciences of the United States of America,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
February 1993, The Journal of biological chemistry,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
April 1994, Journal of immunology (Baltimore, Md. : 1950),
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
September 2021, Journal of clinical pathology,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
February 2000, The Journal of antibiotics,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
January 2003, Current topics in medicinal chemistry,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
November 1988, Biochemistry,
V K Brown, and E W Ogle, and A L Burkhardt, and R B Rowley, and J B Bolen, and L B Justement
March 2001, European journal of immunology,
Copied contents to your clipboard!